Neuropharmacological profile of ethanolic dried seed extract of Persea americana in mice

Persea americana Mill (Lauraceae) is a medicinal plant used traditionally in Nigeria to treat several diseases including malaria, hypertension and febrile convulsions among others. Some of these indications are related to central activity but have not been systematically evaluated. This study investigated the neuropharmacological effects and the acute toxicity profile of the ethanolic dried seed extract of P. americana in mice. Fresh dried grounded seed of P. americana was extracted with 70% ethanol. Acute toxicity (LD50) profile of the ethanolic extract of P. americana (EEPA) at 10 to 5000 mg/kg was determined orally (p.o.) and intraperitoneally (i.p.) in mice. The EEPA was further tested for behavioral, anxiolytic, hypothermic, sedative, anticonvulsant, and anti-nociceptive activities. The LD50 of EEPA was determined to be ≥5000 mg/kg, p.o., and 2250 mg/kg, i.p. The extract at 250 to 1000 mg/kg dose-dependently caused significant (p<0.01 to 0.001) reduction in rearing and locomotor activity, signifying central nervous system (CNS) depression; significantly (p<0.01) lowered normal rectal temperature showing hypothermic effect; shortened onset and increased total sleeping time of ketamine (100 mg/kg, i.p.), suggesting sedative activity;  reduced mortality due to pentylenetetrazole, picrotoxin and strychnine, and blocked hind limb tonic extension on the electro-shock, conveying evidence of anticonvulsant activity; increased reaction time on the hot plate and inhibited acetic acid-induced writhings, indicating analgesic potential. This study reveals significant depressant effect of ethanolic extract of P. americana on the CNS; and manifested hypothermic, sedative, anticonvulsant and anti-nociceptive effects in mice, thus justifying its ethnomedicinal use which can also serve as a lead in drug discovery. 
 
 Key words: Avocado, behavioral, hypnosis, anticonvulsant, nociception.


INTRODUCTION
The use of plants in form of concoction, infusion, decoction, etc., was the order of the day until the development of scientific means of extraction and purification which have paved the way for the identification of the precise compound(s) that is/are responsible for the observed pharmacological responses (Newman and Craig, 2012). In recent years, secondary plant metabolites previously with unknown pharmacological activities have been extensively investigated as sources of medicinal agents. Leads can be obtained in many ways among which are the screening of natural products from plants, animals, minerals and microorganism (Fabricant and Farnsworth, 2001). Of these, plants are the most abundant, diversified and constitutive. Although the modern synthetic methods of drug discovery have revolutionized drug production, plants remain a valuable source of drugs as many important drugs used in medicine today can be traced to plants (Balunas and Kinghorn, 2005).
Persea americana (Lauraceae) commonly known as avocado, has been cultivated for its highly nutritious values since about 8000 BC, and there is evidence that it was eaten as wild fruits before then. It is believed to have originated in Mexico and Central America including the Pacific coasts of Guatemala, El Salvador, Nicaragua, Costa Rica, and Panama (Chen et al., 2008). Avocado is now widely cultivated in large quantities in Indonesia, Brazil, South Africa, Israel, USA (California and Florida) and Australia. Different species of avocado is presently found in several tropical and sub-tropical countries including Nigeria where the fruits are in high demand. In Southwest Nigeria, avocado grows wild in the forests or is planted in selected locations for various purposes including commercial, protection against wind-storms, as shade and other uses. P. americana leaf or fruit is a popular medicinal plant used traditionally in the management of several diseases in many southwestern states of Nigeria where it is indicated for treating malaria, hypertension, rheumatism, febrile convulsions and diabetes among other uses (Owolabi et al., 2005;Anita et al., 2005;Ezuruike and Prieto, 2014). Traditional herbal practitioners recommend taking the seed (fresh or dried) to treat various ailments most importantly, diabetes, hypertension and arthritis.
Various bioactivities of this plant seed have been reported, however, considering the rate and manner of its use in folkloric medicine, there is a need to explore other effects and presently there is no comprehensive study relating these ethnomedicinal claims to central effects. It therefore becomes imperative to investigate its possible effect on the central nervous system (CNS) as a preliminary screening step in our quest for identifying CNS-acting agents from natural products and to provide scientific basis for the various folkloric claims. In this study we set out to assess some central nervous system activities and determine the acute toxicity profile of the ethanolic dried seed of this Nigerian species.

Plant collection, identification, authentication and preparation
Matured fruits of P. americana were purchased in June 2013 from the central market in Ondo Town, Ondo State, Southwest, Nigeria. Mr. Bernard Omomoh, the herbarium officer of Botany Department, Faculty of Sciences, Obafemi Awolowo University, Ile-Ife, identified and authenticated the plant. The herbarium specimen sample of the fruit and leaf was prepared and deposited with reference number IFE 17374. The fruits were allowed to ripen in the laboratory after which their seeds were removed, sliced into smaller pieces and sun-dried for 1 week before powdered into coarse sizes. The powdered seed was macerated with 70% ethanol on a mechanical shaker for 72 h. The mixture was filtered and the filtrate concentrated in vacuo using the rotatory evaporator. The semisolid extract obtained was further freeze-dried to yield 11.60 g (2.9% w /w) ethanolic dried seed extract of P. americana (EEPA) and stored in the refrigerator until use. The hydro-alcoholic (ethanolic) extract of the seed was used in this study in order to maximize the extraction process, namely, both polar and non-polar compounds present in the dried seed would be extracted.

Preliminary phytochemical screening
The EEPA was dissolved in water and screened for the presence of secondary metabolites such as terpenes, alkaloids, flavonoids, tannins, saponins, sterols and glycosides (Mir et al., 2013).

Liquid chromatography-mass spectrometry (LC-MS) analysis of the EEPA
The LC-MS analysis of the EEPA was carried out to obtain the fingerprints of the crude extract and the sample of EEPA was analyzed at Central Analytical Facilities, Stellenbosch University, Stellenbosch, South Africa. The analysis was performed on Waters Synapt G2 Waters UPLC with PDA, detection source was by electrospray positive, Capillary voltage 3 kV, Cone Voltage 15 V and Lock mass was Leucine encephalin.

Laboratory animals
Adult male and female albino mice (Vom strain) weighing between 18 and 25 g were obtained from the Animal House, Department of Pharmacology, Obafemi Awolowo University (OAU), Ile-Ife. The mice were caged sex-wise separately to prevent mating and pregnancy. The animals were supplied with regular food and water throughout the period of study except during experiment. Each mice was used only once for the entire period of study. The animal experiments were conducted within the period of 10.00 a.m. and 4.00 p.m. daily at ambient temperature of 30 ± 2°C. The Postgraduate Research Committee, Faculty of Pharmacy, OAU approved the study with reference number: PHA/2008/075. Guidelines on the care and use of experimental animals published by the National Institute of Health (NIH, 1985), as being implemented by the University Research Committee of OAU was complied with.

Acute toxicity studies
Acute toxicity effect of EEPA was assessed in mice using both intraperitoneal (i.p) and oral (p.o.) routes according to Lorke's method (Lorke, 1983). The method involves using thirteen animals on the whole for a rapid and economic LD50 estimation. For each route, the procedure was divided into 2 phases. The first phase consists of three groups (n=3) at the dose levels of 10, 100, and 1000 mg/kg. The second phase also involve four groups (n=1) at the dose levels of 1000, 1600, 2900, and 5000 mg/kg, respectively. Immediately after treatment, each mouse was placed inside the Plexiglas cage and observed for immediate effects up to 30 min and thereafter for 24 h for lethal effects culminating into death. The LD50 of EEPA was estimated as the geometric mean of the lowest dose causing death and the highest dose causing no death according to the formula below: where A is the maximum dose producing 0% death and B is the dose producing 100% death (Lorke, 1983).

The choice of route of administration
The oral route has been reported to be unpredictable due to effect of many factors including biodegradation of active components, poor bioavailability, effect of food substances etc. (Pond and Tozer, 1984;Castel-Branco et al., 2009;Gavhane and Yadav, 2012). The choice of i.p. route for neuropharmacological evaluation was also supported in previous study (de Carvalho et al., 2001), hence, the i.p. route was chosen in this study. The working doses used in this study were 250, 500 and 1000 mg/kg, i.p. which were lower than half of the LD50 value estimated to be 2250 mg/kg, i.p.

Novelty-induced behavior (NIB): Rearing and locomotion
Novelty-induced behavior was assessed as described by Onigbogi et al. (2000), which were further modified in this study. Five groups (n=5) were randomly selected. Group I was administered the vehicle (5% Tween 80, 10 ml/kg, i.p.). Groups II to IV were injected the EEPA (250, 500 and 1000 mg/kg, i.p.), respectively. Group V was injected diazepam (1 mg/kg, i.p.) as positive control (Gonzalez-Trujano et al., 2006). Mice in all the groups were pretreated 30 min prior to test. Each animal was placed inside the observation cage and assessed for rearing (number of times the animal stand on its hind-limbs with fore limbs in the air or against the wall) for 20 min, and locomotion (the number of lines crossed with all limbs) for the first 10 min.

Effect of EEPA on the elevated plus-maze
Mice were randomly distributed as described in previous sections. After 30 min pretreatment, each mouse was placed in the central intersection of the elevated plus maze (EPM). The time spent in the open and closed arms as well as the number of times the animal enter each arm was recorded for 5 min (Pellow et al., 1985). The results obtained were analyzed and compared among the groups. Diazepam (1 mg/kg) was used as the positive control drug (Adeyemi et al., 2010).

Effect of EEPA on the hole board
Mice were randomly distributed as described in above section. After 30 min pretreatment, each mouse was placed in the center of the hole board. The number of head-poking demonstrated by each mouse in 5 min was recorded. The results were analyzed and compared among the groups. Diazepam (1 mg/kg) was used as the positive control drug (Takeda et al., 1998;Yadav et al., 2008).

Effect of EEPA on normal rectal temperature of mice
Five different groups (n=5) of mice were randomly selected. Group I received vehicle, groups II to IV were administered the extract (250, 500 and 1000 mg/kg, i.p., respectively), while group V was injected diazepam (1 mg/kg, i.p.) as the positive control drug (Vale et al., 1999). Rectal temperatures were initially taken before pretreatment and at 30, 60, 90 and 120 min post treatment. All rectal temperatures were measured with digital thermometer (thermoprobe) inserted 2 cm into the anus of the mouse (Al-Nagger et al., 2003;Oyemitan et al., 2008).

Effect of EEPA on ketamine-induced hypnosis
Ketamine (100 mg/kg, i.p.) was used to induce sleep in mice (Mimura et al., 1990). Mice in different groups (n=5) were pretreated with vehicle, extract (250, 500 and 1000 mg/kg, i.p., respectively) and diazepam (1 mg/kg, i.p.) as positive control drug (Adeyemi et al., 2010) 30 min prior to the administration of ketamine. Each animal was observed for sleep latency (SL) or the onset of sleep (time from injection to time of loss of righting reflex); and the duration of sleep or total sleeping time (TST), that is, time from loss and recovery of consciousness.

Effect of EEPA on chemical and maximal electroshock seizure (MES) convulsion tests
Effect of EEPA on pentylenetetrazole (PTZ)-induced convulsion: Pentylenetetrazole (85 mg/kg, i.p.) was used to induce tonic-clonic convulsion (Swinyard et al., 1989). Five different groups (n=5) of mice were randomly selected. Group I received vehicle, groups II to IV were administered the extract (250, 500 and 1000 mg/kg, i.p., respectively) and group V was injected diazepam (1 mg/kg, i.p.) as positive control drug (Gonzalez-Trujano et al., 2006). The anticonvulsant activity assessment was carried out 30 min prior to injection of PTZ (85 mg/kg, i.p.) and observed for the onset of convulsion, time of death and mortality. Animal that survived beyond 30 min post PTZ injection is assumed to be protected in this model (de Sarro et al., 1999).

Effect of EEPA on picrotoxin-induced convulsion:
The experiment described in section (a) was repeated using picrotoxin (10 mg/kg, i.p) as the convulsant agent and diazepam (2 mg/kg, i.p.) as positive control. The manifestation of tonic-clonic convulsion was then assessed as earlier discussed (de Sarro et al., 1999).

Effect of EEPA on strychnine-induced convulsion:
The experiment described in section (b) was repeated using strychnine (4 mg/kg, i.p.) as the convulsant agent, and diazepam (5 mg/kg, i.p.) as positive control (Shenoy et al., 1982). The manifestation of tonic-clonic convulsion was then assessed as earlier discussed (Swinyard et al., 1989). Each animal was observed for tonic-clonic convulsions and mortality. Animals that survived beyond 30 min were regarded as protected.

Effect of EEPA on MES-induced convulsion:
Electroconvulsive shock was used to induce hind limb tonic extension (HLTE). The electrical stimulus (50 mA, 50 Hz, 0.2 s duration) was applied through the ear lobes by electrode clamp (transauricular-ear-clips), using an Electro-Convulsiometer. Group I was administered the vehicle, groups II to IV were injected the extract (250, 500 and 1000 mg/kg, i.p.), respectively, while Group V was injected phenytoin sodium (25 mg/kg, i.p.) as the positive control drug (Sousa et al., 2009). After 30 min pretreatment, each mouse was submitted to MES test. Protection against HLTE was taken as positive result (Pourgholami et al., 1999).

Effect of EEPA on thermal and chemical nociception in mice
Effect of EEPA on the hot plate test: Mice were randomly allocated to five groups (n=5). Mice in group I were injected vehicle; groups II to IV with EEPA (250, 500 and 1000 mg/kg respectively), and group V with morphine (10 mg/kg) as the positive control drug (Viana et al., 2003). Each mouse was dropped gently on the hot plate maintained at 55°C and the time taken for the mouse to lick the fore or hind paw or jump up on the plate was taken as reaction time, the test was carried out at 30, 60, 90 and 120 min posttreatment. The cut off time was set at 30 s (Silva et al., 2003).

Effect of EEPA on acetic acid-induced writhings:
Five different groups (n=5) of mice were randomly selected. Group I received vehicle, groups II-IV were administered EEPA (250, 500 and 1000 mg/kg, i.p. respectively), while group V was injected diclofenac (100 mg/kg, i.p.) as positive control drug (Gonzalez-Trujano et al., 2006). Thirty minutes after treatment, each mouse was intraperitoneally injected 1% acetic acid (10 ml/kg) and allowed 5 min delay before assessment for up to 20 min inside the Plexiglas's cage. The number of writhings or abdominal constrictions displayed by each mouse was counted and recorded (Viana et al., 2003;Silva et al., 2003).

Statistical analysis
The results were expressed as mean±standard error of mean (SEM) and analyzed using one-way analysis of variance (ANOVA) followed by post hoc test using Dunnett's test for comparison between the treated groups and control. The anticonvulsant results were presented in percentage by comparing the % protection/ mortality in treatment groups versus the negative control group. GraphPad Instat 3 (UK) and GraphPad Prism 5 (© 1990 were used for the analysis of the results.

Preliminary phytochemical test
Results of the preliminary phytochemical screening confirmed the presence of alkaloids, phenols, flavonoids, saponins, terpenes, steroids, and glycosides; however, phytosterols was not detected in the EEPA sample.

LC-MS analysis of the EEPA
The fingerprints of the crude EEPA performed on the LC-MS showed the presence of numerous compounds which can be used as a reference fingerprint for other EEPA crude extract (Figure 1).

Acute toxicity studies
In the oral route, doses of EEPA up to 5000 mg/kg produce no mortality in the mice, and in the intraperitoneal route, there was mortality at 2900 mg/kg but none at 1600 mg/kg; according to Lorke (1983) the LD 50 values were calculated to be ≥5000 and 2154 mg/kg for the oral and intraperitoneal routes, respectively.

Effect of EEPA on novelty-induced behavior
The EEPA ( Figure 2B).

Effect of EEPA on anxiety
The EEPA at 250 mg/kg, i.p. caused significant [p<0.01; F (4, 20) =47] increase in the number of head pokes compared to the vehicle. At the doses of 500 and 1000 mg/kg, i.p. it showed a significant (p<0.05 to 0.01) decrease in the number of head pokes similarly to diazepam (1 mg/kg, i.p.) which also showed significant (p<0.01) decrease in the exploratory activity ( Figure 3). On the EPM, EEPA at all doses did not cause a significant increase in the percentage number of entries into either of the closed or open arms when compared to the control group, showing a lack of anxiolytic effect at these doses (result not shown).

Effect of EEPA on rectal temperature of mice
Vehicle did not cause significant variation in rectal temperature up to 120 min post-treatment.  Figure 4).

Effect of EEPA on chemical and electric shock convulsion tests
The results of chemo-and electro-convulsion tests are summarized in Table 1 (Table 3).

DISCUSSION
In this study, we investigated the effect of the ethanolic extract of the dried seed of P. americana (EEPA) on novelty induced behaviour (NIB), anxiety, rectal temperature, sedation, convulsion and nociception in mice. The acute toxicity profile (LD 50 ) of the extract was also determined orally and intraperitoneally. The major effect of the extract was found to cause depression of the central nervous system. Preliminary phytochemical screening of the EEPA confirmed the presence of alkaloids, phenols, terpenes, flavonoids, saponins, steroids and glycosides similar to report by Arukwe et al. (2012), suggesting that the species used in this and the other studies were the same although they were from different southern states of Nigeria. The EEPA was analysed with liquid chromategraphy and mass spectroscopy (LC-MS) and the chromatogram obtained showed the presence of several compounds (Figure 1) which serves as the fingerprints of the EEPA in this study.
The LD 50 values obtained in the acute toxicity study of the ethanolic extract of the dried seed of P. americana were found to be ≥ 5000 mg/kg, p.o., and 2154 mg/kg, i.p., which indicates that it is non-toxic and moderately toxic through the oral and intraperitoneal routes respectively (Lorke, 1983). However, the values obtained here for the oral route contrasted sharply from that obtained in another study on ethanolic seed extract of a Mexican species, which caused a mortality of 20, 60 and 80% at doses of 500, 1000 and 2000 mg/kg, p.o., respectively (Padilla-Camberos et al., 2013). This could be due to differences in the chemical composition of the extracts occasioned by geographical and species variation (Guo et al., 2013).
This non-toxic effect per oral of this extract may be used to justify the use of this plant in ethnomedicine for managing various ailments. The effect of EEPA on novelty-induced behaviour is suppression of rearing and locomotor activities (Figure 2). Locomotion and rearing are considered horizontal and vertical locomotor activities respectively, thus an increase in these activities signifies excitatory while a decrease indicates inhibitory or sedative effect (Zapata-Sudo et al., 2010). The results obtained here are similar to that reported for ethyl acetate extract of Ipomoea stans, which significantly reduced spontaneous motor activity, protected against PTZinduced convulsion and enhanced the hypnotic effect of pentobarbital in mice (Herrera et al., 2007). The EEPA induced a motor depressant effect, indicating a possible skeletal muscle relaxant and sedative effect (Adeyemi et al., 2006). Inhibitory effect in the CNS is caused either by the augmentation of GABA inhibitory effect by binding to the GABA A receptor like the benzodiazepines (e.g. diazepam), or antagonizing the effect of glutamate by blocking glutamate receptors such as NMDA (e.g. felbamate), AMPA (e.g. topiramate), kainite, glycine, or the metabotropic receptors (Rang et al., 2007).
The elevated plus-maze (EPM) has been adequately demonstrated to be a satisfactory model for testing anxiolytic effect of drugs even when the agent does not act via the benzodiazepine receptors (Söderpalm et al., 1989). The EEPA at all doses used did not show anxiolytic effect on EPM model because there was no significance (p>0.05) increase in the time spent in the open arms and number of entries which could be due to the sedative effect of the extract at the doses used in this study. Previous report revealed that high doses of sedatives cause depression of all activities including exploratory activity (Hellion-Ibarrola et al., 1999). A further anxiolytic test of the extract on the hole-board model ( Figure 3) reveals a positive anxiolytic effect at the lowest dose (250 mg/kg, i.p.) as it increased the level of exploratory activity (number of head dips) when compared to the control group. However, EEPA at 500-1000 mg/kg, i.p., and diazepam (1 mg/kg, i.p.) caused significant reduction in head-dips in this study possibly due to their sedative effect. Sedative agents have been variously reported to decrease exploratory activities on the EPM and on the hole board, but did not preclude them from exhibiting anxiolytic activity (Parka et al., 2005).
The extract (1000 mg/kg, i.p.) significantly (p<0.01) reduced the rectal temperature throughout the 120 min time interval compared to the control (Figure 4). The hypothalamus has been reported to regulate body temperature, and CNS-depressants such as hypnotics, general anaesthesia and benzodiazepines normally lower body temperature at relatively low doses (Vale et al., 1999). The result obtained in this study suggests that the extract may be causing reduction in body temperature mainly through the hypothalamus which has been widely linked to body temperature regulation (Bhattacharya et al., 2003;Nagashima, 2006).
The EEPA at all doses significantly (p<0.05-0.01) decreased SL and increased TST induced by ketamine in a dose dependent manner ( Figure 5A and B) comparable to diazepam (1 mg/kg, i.p.). Reduction in SL and prolongation of TST indicate sedative effect (Hellion-Ibarrola et al., 1999), which may involve enhancement of neurotransmission of GABA in the CNS (Sivam et al., 2004) by potentiating the inhibitory influence of GABA. Sedatives are known to induce deep rest in humans and it has been shown that when patients have sufficient sleep, circadian variation in blood pressure and heart rate is significantly decreased (Rowlands et al., 1980) and by inference may contribute to its hypotensive activity.
Adverse effects of available anticonvulsant drugs make treatment difficult hence the demand for new anticonvulsants is increasingly necessitated and one of the approaches to searching for new antiepileptic drugs is   i.p.). The extract at all doses used and diazepam in this study offered 100 % protection, signifying the involvement of GABA A -benzodiazepine pathway in the mediation of this activity (Olatokunboh et al., 2009). PTZ-induced seizure is analogous to petit-mal type of seizures and human generalized seizures (Löscher and Schmidt, 1988). The mechanism by which PTZ is believed to exert its action is by acting as an antagonist at the GABA A receptor complex (Ramanjaneyulu et al., 1984). On the other hand, drugs that reduce T-type Ca 2+ currents, such as ethosuximide can prevent seizures induced by PTZ (Karunakar et al., 2009). Drugs that are effective against petit-mal seizures reduce T-type calcium currents, and drugs that enhance GABAA-BZD receptor mediated neurotransmission such as benzodiazepines and phenobarbitone (McDonald and Kelly, 1995) can prevent these types of seizures. Studies have shown that activation of N-methyl-D-aspartate receptor (NMDA) is also involved in the initiation and generalization of PTZ-induced seizures (Nevis and Arnolde, 1989). The EEPA at 500 and 1000 mg/kg, i.p. offered 60 and 80% protections, respectively while diazepam (2 mg/kg, i.p.) offered 80% protection. Picrotoxin is a potent antagonist of the GABA A receptor, and it binds at the β 2 /β 3 subunits of the receptor to effectively block the chloride channel, resulting in a postsynaptic neuron that is more easily excitable and prone to hyper-excitability (McDonald and Kelly, 1995). The extract profoundly delayed the onset and inhibited strychnine-induced seizures in a dose-dependent manner. The only dose of the extract that offered protection in this model provided 60% protection compared to diazepam (5  mg/kg, i.p.), which offered 40% protection. Strychnine has been shown to act by directly antagonizing glycine at spinal cord and brainstem, thus increasing spinal reflexes (Olatokunboh et al., 2009). It could be suggested that EEPA may be exerting its anticonvulsant effect through augmentation of glycine transmission in the spinal cord and brain stem. The EEPA at 500 and 1000 mg/kg, i.p. successfully blocked the HLTE induced by the MES which was comparable to the standard drug (phenytoin sodium, 25 mg/kg, i.p.) suggesting potential antiepileptic activity against generalized tonic-clonic and partial seizures which might be acting probably through blockage of Ca ++ or Na + or both ). Anticonvulsant activity of the aqueous leaf extract of P. americana from Nigeria has been reported earlier (Ojewole and Amabeoku, 2006), suggesting that the active component(s) may be present in the leaf and seed of the plant.
The extract at all doses used significantly (p<0.01) prolonged the reaction to thermal stimulation on the hot plate test, which was comparable to morphine (10 mg/kg, i.p.), a standard opioid agonist (Table 2). Our findings demonstrated significant (p<0.01) activity of EEPA in the hot-plate model in a dose dependent manner which has been linked to central mediation. The pain inhibition effect of the extract, at the highest dose (1000 mg/kg, i.p.), was significant (p<0.01) throughout the period of observation (120 min), whereas the standard drug, morphine (10 mg/kg, i.p.) reached its peak effect at 90 min after which its effect became negligible. Acetic acid-induced writhing test was used to confirm the peripheral analgesic activity of the EEPA. The EEPA at all doses used significantly (p<0.01) inhibited acetic acid-induced writhes in mice ( Table 3). The extract at 250, 500 and 1000 mg/kg, i.p. offered 33, 55 and 86% analgesia respectively compared to diclofenac's 86%, signifying peripheral analgesic activity (Silva et al., 2003). The analgesic result obtained here corroborates earlier report on the analgesic activity of the leaf extract (Adeyemi et al., 2002). Prostaglandins induce abdominal constriction by activating and sensitizing the peripheral chemo-sensitive nociceptors which are mostly responsible for causing inflammatory pain (Delevalcee et al., 1980). The results obtained from the hot plate and acetic acid-induced writhings suggested that the EEPA may mediate these anti-nociceptive activities centrally and peripherally, thus providing rationale for the ethnomedicinal use of the seed of this plant in the management of pain and rheumatism.
Further studies to isolate the active principles in this plant is imperative which can lead to discovery of novel and potent drugs that will be invaluable in mitigating myriads of diseases ravaging mankind.

Conclusion
It is concluded that major effect of the ethanolic dried seed extract of P. americana is depression of the central nervous system which also manifested significant hypothermic, sedative, anticonvulsant and analgesic activities in mice; thus, providing scientific basis and justification for the ethnomedicinal uses of the plant in addition to serving as a clue in the discovery of novel and useful therapeutical agent.